Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

aTyr Pharma Inc (NASDAQ:LIFE)

3.23
Delayed Data
As of May 27
 +0.02 / +0.62%
Today’s Change
2.81
Today|||52-Week Range
28.29
-67.14%
Year-to-Date
No recent news for aTyr Pharma Inc.

Today’s Trading

Previous close3.21
Today’s open3.22
Day’s range3.17 - 3.36
Volume99,892
Average volume (3 months)338,336
Market cap$76.5M
Dividend yield--
Data as of 3:59pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-25.21%
Earnings growth (this year)+9.64%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.04-0.49%
PVCTProvectus Biopharmac...+0.01+3.11%
DRNADicerna Pharmaceutic...+0.01+0.27%
CHMAChiasma Inc+0.08+2.65%
Data as of 4:01pm ET, 05/27/2016

Financials

Next reporting dateAugust 10, 2016
EPS forecast (this quarter)-$0.73
Annual revenue (last year)$0.00
Annual profit (last year)-$48.0M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
John D. Mendlein
Vice President-
Clinical Affairs
Kelly Blackburn
Corporate headquarters
San Diego, California

Forecasts

Partner Offers

Search for Jobs